Literature DB >> 31907996

Mdm2 is a target and mediator of IRP2 in cell growth control.

Jin Zhang1, Xiangmudong Kong1, Yanhong Zhang1, Wenqiang Sun1, Enshun Xu1, Xinbin Chen1.   

Abstract

Iron is an essential element to all living organisms and plays a vital role in many cellular processes, such as DNA synthesis and energy production. The Mdm2 oncogene is an E3 ligase and known to promote tumor growth. However, the role of Mdm2 in iron homeostasis is not certain. Here, we showed that Mdm2 expression was increased by iron depletion but decreased by iron repletion. We also showed that Iron Regulatory Protein 2 (IRP2) mediated iron-regulated Mdm2 expression. Specifically, Mdm2 expression was increased by ectopic IRP2 but decreased by knockdown or knockout of IRP2 in human cancer cells as well as in mouse embryonic fibroblasts. In addition, we showed that IRP2-regulated Mdm2 expression was independent of tumor suppressor p53. Mechanistically, we found that IRP2 stabilized Mdm2 transcript via binding to an iron response element (IRE) in the 3'UTR of Mdm2 mRNA. Finally, we showed that Mdm2 is required for IRP2-mediated cell proliferation and Mdm2 expression is highly associated with IRP2 in both the normal and cancerous liver tissues. Together, we uncover a novel regulation of Mdm2 by IRP2 via mRNA stability and that the IRP2-Mdm2 axis may play a critical role in cell growth.
© 2019 Federation of American Societies for Experimental Biology.

Entities:  

Keywords:  IRP2; Iron homeostasis; Iron-response element (IRE); Mdm2; mRNA stability

Mesh:

Substances:

Year:  2019        PMID: 31907996      PMCID: PMC7018553          DOI: 10.1096/fj.201902278RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  39 in total

1.  Hydroxyl radical production and human DNA damage induced by ferric nitrilotriacetate and hydrogen peroxide.

Authors:  S Inoue; S Kawanishi
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

Review 2.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

3.  Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line.

Authors:  L Cahilly-Snyder; T Yang-Feng; U Francke; D L George
Journal:  Somat Cell Mol Genet       Date:  1987-05

4.  Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.

Authors:  Paola Dongiovanni; Anna Ludovica Fracanzani; Gaetano Cairo; Chiara Paola Megazzini; Stefano Gatti; Raffaela Rametta; Silvia Fargion; Luca Valenti
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 5.  p53-independent functions of MDM2.

Authors:  Gitali Ganguli; Bohdan Wasylyk
Journal:  Mol Cancer Res       Date:  2003-12       Impact factor: 5.852

6.  Genetic Ablation of Rbm38 Promotes Lymphomagenesis in the Context of Mutant p53 by Downregulating PTEN.

Authors:  Jin Zhang; Enshun Xu; Cong Ren; Hee Jung Yang; Yanhong Zhang; Wenqiang Sun; Xiangmudong Kong; Weici Zhang; Mingyi Chen; Eric Huang; Xinbin Chen
Journal:  Cancer Res       Date:  2018-01-12       Impact factor: 12.701

Review 7.  MDM2 overexpression, activation of signaling networks, and cell proliferation.

Authors:  Swati Palit Deb; Shilpa Singh; Sumitra Deb
Journal:  Subcell Biochem       Date:  2014

8.  Casein kinase type II is involved in the inhibition by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole of specific RNA polymerase II transcription.

Authors:  R Zandomeni; M C Zandomeni; D Shugar; R Weinmann
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

9.  MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.

Authors:  E Xu; J Zhang; X Chen
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

10.  Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis.

Authors:  Yoshiharu Muto; Toshiro Moroishi; Kazuya Ichihara; Masaaki Nishiyama; Hideyuki Shimizu; Hidetoshi Eguchi; Kyoji Moriya; Kazuhiko Koike; Koshi Mimori; Masaki Mori; Yuta Katayama; Keiichi I Nakayama
Journal:  J Exp Med       Date:  2019-03-15       Impact factor: 14.307

View more
  3 in total

1.  Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents.

Authors:  Paul Lee; Rita Yim; Kai-Kei Miu; Sin-Hang Fung; Jason Jinyue Liao; Zhangting Wang; Jun Li; Yammy Yung; Hiu-Tung Chu; Pui-Kwan Yip; Emily Lee; Eric Tse; Yok-Lam Kwong; Harinder Gill
Journal:  Int J Mol Sci       Date:  2022-05-18       Impact factor: 6.208

Review 2.  Iron and Cancer: 2020 Vision.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Cancer Res       Date:  2020-09-14       Impact factor: 12.701

Review 3.  Iron: The cancer connection.

Authors:  Suzy V Torti; Frank M Torti
Journal:  Mol Aspects Med       Date:  2020-04-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.